| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 17, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $51.83 | $207,320.00 | -16.7% | |
| May 17, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $52.20 | $52,200.00 | -3.3% | |
| May 17, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $51.82 | $2,054,026.68 | -0.3% | |
| May 9, 2018 | Routti Jorma | Director | Sale+OE | 6,000 | $47.10 | $282,600.00 | -4.5% | |
| May 3, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $47.04 | $1,864,353.10 | -0.4% | |
| Apr 19, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $47.69 | $190,760.00 | -16.7% | |
| Apr 19, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $47.70 | $47,700.00 | -3.3% | |
| Apr 18, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $48.56 | $1,924,629.52 | -0.3% | |
| Apr 16, 2018 | Yu K Peony | Chief Medical Officer | Sell | 7,500 | $47.81 | $358,553.00 | -2.4% | |
| Apr 9, 2018 | Routti Jorma | Director | Sale+OE | 6,000 | $46.59 | $279,554.00 | -2.3% |